Dicyclomine Injection Suppliers & Bulk Manufacturers
Available Forms: injection
Available Strengths: 10mg/ml
Reference Brands: Bentyl(US)
Category:
Gastrointestinal Drugs
Dicyclomine is an antispasmodic that blocks muscarinic receptors, reducing smooth muscle contractions in the gastrointestinal tract. It relieves severe GI spasms, cramping, and associated pain. Benefits include symptom relief, improved digestion, decreased abdominal discomfort, and support for diagnostic procedures involving bowel relaxation and motility assessment.
Dicyclomine injection is available in injection
and strengths such as 10mg/ml.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Dicyclomine injection is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Dicyclomine injection can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Dicyclomine injection, marketed as Bentyl, is approved in the US by the FDA and in the EU via EMA for severe gastrointestinal spasms and diagnostic procedures. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing standards. For dossier preparation, regulatory pathways, and market access guidance, visit PharmaTradz. Regulatory adherence supports swift approval, safe administration, and global availability, enabling effective management of severe GI conditions and supporting patient care worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing